Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
CAVA | CAVA GROUP, INC. | Director | $1.28B | -$2.35B | -64.9% | Nov 18, 2024 |
LXRX | LEXICON PHARMACEUTICALS, INC. | Director, 10%+ Owner | $357M | May 10, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|